;

SARC Clinical Studies Now Recruiting

Spotlight

MARCH SARC TALK

This episode showcases Dr. Albiruni Razak from the University of Toronto, Princess Margaret Cancer Center, and Dr. Neeta Somaiah from MD Anderson Cancer Center. Both experts bring a wealth of sarcoma knowledge, particularly focusing on well-differentiated and dedifferentiated liposarcoma.

Listen Now

SARC Tumor Board logo

SARC Multidisciplinary Tumor Board (SMTB) Updates

The SARC Multidisciplinary Tumor Board (SMTB) meets the second Friday of every month at 1:00 p.m. ET. Since inception 21 cases have been discussed. Click to learn more about the cases.

  • Friday
  • May 31
  • 2024


WHAT ARE SARCOMAS?

Sarcomas are uncommon and there are many different types — experts have identified more than 80 different forms — leading to significant diagnostic and therapeutic challenges. Sarcomas represent 15 to 20% of childhood cancers and 1% of adult cancers.

LEARN MORE

young child sarcoma patient

WHAT DOES SARC DO?

Founded in 2003 as a non-profit cancer research organization, SARC directly develops, sponsors, and manages research projects for pediatric and adult sarcomas. We lead domestic and international collaborative discovery, translational research, and clinical trials.

LEARN MORE

Microscope Pink

WHO PARTNERS WITH SARC?

We collaborate with the scientific research community, partner with pharmaceutical and biotech companies, and inform patients and caregivers about our work. Attend our bi-annual meetings to learn more about the latest developments in sarcoma research.

LEARN MORE

Back to top